Table 2: Sample mean score differences between demographic and clinical.

Monitor

M (SD)
Blunter

M (SD)
Gender

  Male

  Female


3.26 (2.12)

3.63 (1.82)


1.95 (1.33)

2.27 (1.48)
Race

  White

  African American

  Other


3.66 (1.91)

2.88 (1.66)

3.66 (1.85)


2.19 (1.43

2.24 (1.55)

2.33 (1.59)
Age Group (years)

  18-44 years

  45-64 years

  ≥65 years


  4.08 (2.30)*

3.43 (1.80)

3.54 (1.79)


2.06 (1.33)

2.29 (1.54)

2.10 (1.32)
Education levelb

  ≤High school diploma

  At least some college

  Completed college or greater


3.04 (1.94)

3.26 (1.71)

3.92 (1.92)


2.22 (1.35)

2.22 (1.40)

2.19 (1.53)
Arthritis Typeb

  Osteoarthritis

  Rheumatoid Arthritis


3.49 (1.88)

3.74 (1.89)


2.36 (1.50)

2.10 (1.41)
Medication Typeb

  DMARD/biologic agent

  No DMARD/biologic agent


3.92 (1.79)

3.44 (1.89)


2.12 (1.45)

2.28 (1.45)
Medication adherence

  Medication taken ≤74% as directed

  Medication taken ≥75% as directed


3.67 (2.03)

3.61 (1.82)


2.18 (1.29)

2.25 (1.48)
Arthritis Duration (years) b

  <5 years

  6-20 years

  > 20 years


3.50 (1.89)

3.52 (1.86)

3.60 (2.04)


2.11 (1.42)

2.37 (1.54)

1.84 (1.19)

a Other includes American Indian/Alaska Native, Asian, Hispanic or Latino, and Native Hawaiian/Pacific Islander
b Number of subjects with non-missing data used as the denominator